LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 14.50 | 770.25 | 1390 | 1497 | 0.9284 | 0.8508 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 14.50 | 770.25 | 1705 | 1497 | 1.1388 | 1.2902 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 16.73 | 770.25 | 1537 | 1664 | 0.9234 | 0.8617 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 16.73 | 770.25 | 1839 | 1664 | 1.1048 | 1.1876 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 18.95 | 770.25 | 1692 | 1832 | 0.9233 | 0.8764 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 18.95 | 770.25 | 2015 | 1832 | 1.0996 | 1.1578 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 21.17 | 770.25 | 1830 | 2008 | 0.9112 | 0.8699 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 21.17 | 770.25 | 2225 | 2008 | 1.1079 | 1.1538 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 23.39 | 770.25 | 2037 | 2244 | 0.9076 | 0.8781 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 23.39 | 770.25 | 2471 | 2244 | 1.1009 | 1.1286 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 25.62 | 770.25 | 2285 | 2514 | 0.9086 | 0.8908 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 25.62 | 770.25 | 2764 | 2514 | 1.0991 | 1.1138 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 27.84 | 770.25 | 2564 | 2833 | 0.9048 | 0.8963 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 27.84 | 770.25 | 3054 | 2833 | 1.0777 | 1.0812 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 30.06 | 770.25 | 2865 | 3106 | 0.9224 | 0.9213 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 30.06 | 770.25 | 3385 | 3106 | 1.0898 | 1.0873 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 32.28 | 770.25 | 3099 | 3392 | 0.9134 | 0.9171 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 32.28 | 770.25 | 3653 | 3392 | 1.0767 | 1.0703 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 34.50 | 770.25 | 3370 | 3712 | 0.9079 | 0.9166 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 34.50 | 770.25 | 3993 | 3712 | 1.0757 | 1.0654 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 36.73 | 770.25 | 3678 | 4086 | 0.9001 | 0.9145 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 36.73 | 770.25 | 4389 | 4086 | 1.0741 | 1.0603 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 38.95 | 770.25 | 4001 | 4543 | 0.8805 | 0.9031 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 38.95 | 770.25 | 4828 | 4543 | 1.0625 | 1.0479 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 41.17 | 770.25 | 4399 | 5010 | 0.8779 | 0.9059 | MN20160304_L02 | E19 |